Lilly, Novo Nordisk closer to deal with Trump administration to slash obesity drug prices to $149/month
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The integration of AHG’s specialized cold chain transportation and third-party logistics (3PL) solutions will significantly strengthen UPS Healthcare’s service offerings
Orphan drug designation (ODD) by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Kygevvi combines two pyrimidine nucleosides, doxecitine and doxribtimine, which act by integrating deoxycytidine and deoxythymidine into skeletal muscle mitochondrial DNA
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Upon completion, Kimberly-Clark shareholders are expected to own about 54% of the combined entity, while Kenvue shareholders will hold the remaining 46%
Subscribe To Our Newsletter & Stay Updated